Humoral and cellular immune responses to myelin protein peptides in chronic inflammatory demyelinating polyradiculoneuropathy

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 80, Issue 3, 2009, Pages 333-338

  Sanvito, L ^a,b,c   Makowska, A ^a   Mahdi Roger, M ^a   Hadden, R D M ^a   Peakman, M ^a   Regson, N G ^a   Nemni, R ^b   Hughes, R A C ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF MILAN   (Italy)

^c QUEEN S MEDICAL CENTRE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; GAMMA INTERFERON; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; INTERLEUKIN 10; INTERLEUKIN 17; MYELIN BASIC PROTEIN; MYELIN PROTEIN; PERIPHERAL MYELIN PROTEIN 22; CYTOKINE; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; P2 PEPTIDE; PEPTIDE FRAGMENT; PMP22 PROTEIN, HUMAN;

AGED; ARTICLE; AUTOIMMUNE DISEASE; CELLULAR IMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RESPONSIVE ELEMENT; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME LINKED IMMUNOSPOT ASSAY; FEMALE; HEREDITARY MOTOR SENSORY NEUROPATHY; HUMAN; HUMAN CELL; HUMORAL IMMUNITY; MALE; NEUROPATHY; PERIPHERAL NEUROPATHY; POLYNEUROPATHY; POLYRADICULONEUROPATHY; PRIORITY JOURNAL; ADULT; BLOOD; CELL CULTURE; IMMUNOLOGY; MIDDLE AGED;

ADULT; AGED; AUTOANTIBODIES; CELLS, CULTURED; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNITY, CELLULAR; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INTERFERON-GAMMA; INTERLEUKIN-10; INTERLEUKIN-17; MALE; MIDDLE AGED; MYELIN P0 PROTEIN; MYELIN PROTEINS; PEPTIDE FRAGMENTS; POLYRADICULONEUROPATHY, CHRONIC INFLAMMATORY DEMYELINATING;

EID: 61549143343     PISSN: 00223050     EISSN: 1468330X     Source Type: Journal    
DOI: 10.1136/jnnp.2008.159798     Document Type: Article

References (30)

1. Hughes RAC, Bouche P, Cornblath DR, et al. European Federation of Neurological Societies/Peripheral Nerve Society guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society. Eur J Neurol 2006;13:326-32.
2. Hughes RAC, Allen D, Makowska A, Gregson NA. Pathogenesis of chronic inflammatory demyelinating polyradiculoneuropathy. J Peripher Nerv Syst 2006;11:30-46.
3. Koller H, Kieseier BC, Jander S, et al. Chronic inflammatory demyelinating polyneuropathy. New Engl J Med 2005;352:1343-56.
4. Yan WX, Archelos JJ, Hartung HP, et al. P0 protein is a target antigen in chronic inflammatory demyelinating polyradiculoneuropathy. Ann Neurol 2001;50:286-92.
5. Csurhes PA, Sullivan AA, Green K, et al. T cell reactivity to P0, P2, PMP-22, and myelin basic protein in patients with Guillain-Barreá syndrome and chronic inflammatory demyelinating polyradiculoneuropathy. J Neurol Neurosurg Psychiatry 2005;76:1431-9.
6. Willison HJ, Yuki N. Peripheral neuropathies and anti-glycolipid antibodies. Brain 2002;125:2591-625.
7. Uyemura K, Asou H, Takeda Y. Structure and function of peripheral nerve myelin proteins. Prog Brain Pes 1995;105:311-18.
8. Meyer zu Horste G, Hartung HP, Kieseier BC. From bench to bedside-experimental rationale for immune-specific therapies in the inflamed peripheral nerve. Nat Clin Pract Neurol 2007;3:198-211.
9. Allen D, Giannopoulos K, Gray I, et al. Antibodies to peripheral nerve myelin proteins in chronic inflammatory demyelinating polyradiculoneuropathy. J Peripher Nerv Syst 2005;10:174-80.
10. Gabriel CM, Gregson NA, Hughes RA. Anti-PMP22 antibodies in patients with inflammatory neuropathy. J Neuroimmunol 2000;104:139-46.
11. Inglis HR, Csurhes PA, McCombe PA. Antibody responses to peptides of peripheral nerve myelin proteins P0 and P2 in patients with inflammatory demyelinating neuropathy. J Neurol Neurosurg Psychiatry 2007;78:419-22.
12. Khalili-Shirazi A, Atkinson P, Gregson N, et al. Antibody responses to PO and P2 myelin proteins in Guillain-Barré syndrome and chronic idiopathic demyelinating polyradiculoneuropathy. J Neumimmunol 1993;46:245-51.
13. Kwa MS, Van Schaik IN, Brand A, et al. Investigation of serum response to PMP22, connexin 32 and P(0) in inflammatory neuropathies. J Neumimmunol 2001;116:220-5.
14. Hughes RA, Gray IA, Gregson NA, et al. Immune responses to myelin antigens in Guillain-Barré syndrome. J Neumimmunol 1984;6:303-12.
15. Meléndez-Vásquez C, Redford J, Choudhary PP, et al. Immunological investigation of chronic inflammatory demyelinating polyradiculoneuropathy. J Neumimmunol 1997;73:124-34.
16. Ritz MF, Lechner-Scott J, Scott RJ, et al. Characterisation of autoantibodies to peripheral myelin protein 22 in patients with hereditary and acquired neuropathies. J Neumimmunol 2000;104:155-63.
17. Khalili-Shirazi A, Hughes RAC, Brostoff S, et al. T cell response to myelin proteins in Guillain-Barré syndrome. J Neurol Sci 1992;111:200-3.
18. Lin JT, Rowe V, Brostoff SW, et al. Lymphocyte studies in a patient with chronic polyradiculoneuropathy. Neurology 1982;32:1127-32.
19. Taylor WA, Brostoff SW, Hughes RAC. P2 specific lymphocyte transformation in Guillain-Barré syndrome and chronic idiopathic demyelinating polyradiculoneuropathy. J Neurol Sci 1991;104:52-5.
20. Zweiman B, Rostami A, Lisak RP, et al. Immune reactions to P2 protein in human inflammatory demyelinative neuropathies. Neurology 1983;33:234-7.
21. Hughes RAC, Umapathi T, Gray IA, et al. A controlled investigation of the cause of chronic idiopathic axonal polyneuropathy. Brain 2004;127:1723-30.
22. Makowska A, Pritchard J, Sanvito L, et al. Immune responses to myelin proteins in Guillain-Barré syndrome. J Neurol Neurosurg Psychiatry 2008;79:664-71.
23. Mei FJ, Ishizu T, Murai H, et al. Th1 shift in CIDP versus Th2 shift in vasculitic neuropathy in CSF. J Neurol Sci 2005;228:75-85.
24. Misawa S, Kuwabara S, Mori M, et al. Serum levels of tumor necrosis factor-oc in chronic inflammatory demyelinating polyneuropathy. Neurology 2001;56:666-9.
25. Horiuchi I, Ochi H, Murai H, et al. Th2 shift in mononeuritis multiplex and increase of Th2 cells in chronic inflammatory demyelinating polyneuropathy: an intracellular cytokine analysis. J Neurol Sci 2001;193:49-52.
26. Inoue A, Iwahashi T, Koh CS, et al. A study on subpopulation of helper T cells in chronic inflammatory demyelinating polyneuropathy. Arerugi 1994;43:1270-6.
27. Roncarolo MG, Battaglia M, Gregori S. The role of interleukin 10 in the control of autoimmunity. J Autoimmun 2003;20:269-72.
28. Bettelli E, Oukka M, Kuchroo VK. TH-17 cells in the circle of immunity and autoimmunity. Nat Immunol 2007;8:345-50.
29. Komiyama Y, Nakae S, Matsuki T, et al. IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis. J Immunol 2006;177:566-73.
30. Suryani S, Sutton I. An interferon-γ-producing Th1 subset is the major source of IL- 17 in experimental autoimmune encephalitis. J Neumimmunol 2007;183:96-103.